<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35225120</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1521-0464</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drug delivery</Title>
          <ISOAbbreviation>Drug Deliv</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dendritic cell combination therapy reduces the toxicity of triptolide and ameliorates colitis in murine models.</ArticleTitle>
        <Pagination>
          <StartPage>679</StartPage>
          <EndPage>691</EndPage>
          <MedlinePgn>679-691</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/10717544.2022.2044935</ELocationID>
        <Abstract>
          <AbstractText>Triptolide (TP) exerts a promising effect in the treatment of ulcerative colitis (UC). However, its toxicity seriously hinders its application in the clinic. Previous studies indicated that dendritic cells (DCs) are the main target through which TP exerts its immunoregulatory effect. Thus, we designed an approach to target DCs <i>in vitro</i> to avoid the direct exposure of organs to TP. Our results revealed that DCs pretreated with TP (DCTP) exerted satisfactory therapeutic effects in mice with colitis, resulting in improved colonic inflammation and alleviated local lesion damage. In addition, no obvious toxicity was observed. DCTP also reshaped the immune milieu by decreasing CD4<sup>+</sup> T cell numbers and increasing regulatory T cell numbers in the spleen, mesenteric lymph nodes, peripheral blood and colon; these effects were further confirmed <i>in vitro</i>. Downregulation of CD80/86, ICAM-1, MHCI, TLR2/4, TNF-α, and IL-6 expression and upregulation of programmed cell death ligand 1 (PDL1) and IL-10 expression were observed, indicating that DCs were converted into tolerogenic DCs. In conclusion, DCTP can effectively reduce toxicity and alleviate colonic inflammation and local lesion damage in mice with colitis. The immune mechanism underlying the effects of DCTP included the conversion of DCs into tolerogenic DCs and the alteration of T cell differentiation to produce immunoinhibitory rather than immunostimulatory T cells.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rao</LastName>
            <ForeName>Quan</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Beijing Key Laboratory of Cancer Invasion and Metastasis Research &amp; National Clinical Research Center for Digestive Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Guang-Chao</ForeName>
            <Initials>GC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Hao</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Meng</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Beijing Key Laboratory of Cancer Invasion and Metastasis Research &amp; National Clinical Research Center for Digestive Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Guo-Jun</ForeName>
            <Initials>GJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Beijing Key Laboratory of Cancer Invasion and Metastasis Research &amp; National Clinical Research Center for Digestive Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Dong</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Beijing Key Laboratory of Cancer Invasion and Metastasis Research &amp; National Clinical Research Center for Digestive Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Cong-En</ForeName>
            <Initials>CE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Zhi-Jie</ForeName>
            <Initials>ZJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Zhong-Tao</ForeName>
            <Initials>ZT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Beijing Key Laboratory of Cancer Invasion and Metastasis Research &amp; National Clinical Research Center for Digestive Diseases, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Drug Deliv</MedlineTA>
        <NlmUniqueID>9417471</NlmUniqueID>
        <ISSNLinking>1071-7544</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004224">Diterpenes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004852">Epoxy Compounds</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010616">Phenanthrenes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>19ALD1S53J</RegistryNumber>
          <NameOfSubstance UI="C001899">triptolide</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003092" MajorTopicYN="Y">Colitis</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003713" MajorTopicYN="Y">Dendritic Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004224" MajorTopicYN="N">Diterpenes</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004852" MajorTopicYN="N">Epoxy Compounds</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010616" MajorTopicYN="N">Phenanthrenes</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Triptolide</Keyword>
        <Keyword MajorTopicYN="N">dendritic cell</Keyword>
        <Keyword MajorTopicYN="N">tolerogenic</Keyword>
        <Keyword MajorTopicYN="N">toxicity</Keyword>
        <Keyword MajorTopicYN="N">ulcerative colitis</Keyword>
      </KeywordList>
      <CoiStatement>The authors disclose no conflicts.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>28</Day>
          <Hour>8</Hour>
          <Minute>55</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35225120</ArticleId>
        <ArticleId IdType="pmc">PMC8890574</ArticleId>
        <ArticleId IdType="doi">10.1080/10717544.2022.2044935</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Amarnath S, Mangus CW, Wang JC, et al.  (2011). The PDL1–PD1 axis converts human TH1 cells into regulatory T cells. Sci Transl Med
3:111ra120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3235958</ArticleId>
            <ArticleId IdType="pubmed">22133721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arasanz H, Gato-Canas M, Zuazo M, et al.  (2017). PD1 signal transduction pathways in T cells. Oncotarget
8:51936–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5584302</ArticleId>
            <ArticleId IdType="pubmed">28881701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boirivant M, Fuss IJ, Ferroni L, et al.  (2001). Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis. J Immunol
166:3522–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11207312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chuma M, Terashita K, Sakamoto N. (2015). New molecularly targeted therapies against advanced hepatocellular carcinoma: from molecular pathogenesis to clinical trials and future directions. Hepatol Res
45:E1–E11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25472913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D'Argenio G, Valenti M, Scaglione G, et al.  (2006). Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. FASEB J
20:568–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16403786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Engel MA, Kellermann CA, Burnat G, et al.  (2010). Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis. J Physiol Pharmacol
61:89–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20228420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han R, Rostami-Yazdi M, Gerdes S, Mrowietz U. (2012). Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases. Br J Clin Pharmacol
74:424–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3477344</ArticleId>
            <ArticleId IdType="pubmed">22348323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoivik ML, Moum B, Solberg IC, et al.  (2013). Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN study. Gut
62:368–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22717453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Izcue A, Coombes JL, Powrie F. (2006). Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev
212:256–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16903919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jakubzick C, Tacke F, Llodra J, et al.  (2006). Modulation of dendritic cell trafficking to and from the airways. J Immunol
176:3578–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16517726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan S, Greenberg JD, Bhardwaj N. (2009). Dendritic cells as targets for therapy in rheumatoid arthritis. Nat Rev Rheumatol
5:566–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2884969</ArticleId>
            <ArticleId IdType="pubmed">19798032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi T, Siegmund B, Le Berre C, et al.  (2020). Ulcerative colitis. Nat Rev Dis Primers
6:74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32913180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kushwah R, Wu J, Oliver JR, et al.  (2010). Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. Eur J Immunol
40:1022–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4603937</ArticleId>
            <ArticleId IdType="pubmed">20101618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, Han Y, Sun E. (2016). Sniping the scout: targeting the key molecules in dendritic cell functions for treatment of autoimmune diseases. Pharmacol Res
107:27–41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26931618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li XJ, Jiang ZZ, Zhang LY. (2014). Triptolide: progress on research in pharmacodynamics and toxicology. J Ethnopharmacol
155:67–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24933225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lichtenstein GR, Rutgeerts P, Sandborn WJ, et al.  (2012). A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease. Am J Gastroenterol
107:1051–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3390465</ArticleId>
            <ArticleId IdType="pubmed">22613901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Q, Chen T, Chen G, et al.  (2007). Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways. Mol Immunol
44:2686–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17223196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matta R, Wang X, Ge H, et al.  (2009). Triptolide induces anti-inflammatory cellular responses. Am J Transl Res
1:267–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2776323</ArticleId>
            <ArticleId IdType="pubmed">19956437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murano M, Maemura K, Hirata I, et al.  (2000). Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol
120:51–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1905625</ArticleId>
            <ArticleId IdType="pubmed">10759763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ng SC, Lam YT, Tsoi KK, et al.  (2013). Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther
38:854–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23981095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park CH, Lee AR, Ahn SB, et al.  (2020). Role of innate lymphoid cells in chronic colitis during anti-IL-17A therapy. Sci Rep
10:297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6962146</ArticleId>
            <ArticleId IdType="pubmed">31941937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poltorak A, Smirnova I, He X, et al.  (1998). Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis
24:340–55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10087992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rao Q, Zuo B, Lu Z, et al.  (2016). Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro. Hepatology
64:456–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26990897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva FA, Rodrigues BL, Ayrizono ML, Leal RF. (2016). The immunological basis of inflammatory bowel disease. Gastroenterol Res Pract
2016:2097274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5192315</ArticleId>
            <ArticleId IdType="pubmed">28070181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tatiya-Aphiradee N, Chatuphonprasert W, Jarukamjorn K. (2018). Immune response and inflammatory pathway of ulcerative colitis. J Basic Clin Physiol Pharmacol
30:1–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30063466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toruner M, Loftus
EV, Jr., Harmsen WS, et al.  (2008). Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology
134:929–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18294633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungaro R, Mehandru S, Allen PB, et al.  (2017). Ulcerative colitis. Lancet
389:1756–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6487890</ArticleId>
            <ArticleId IdType="pubmed">27914657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu H, Rao Q, Ma GC, et al.  (2019). Effect of triptolide on dextran sodium sulfate-induced ulcerative colitis and gut microbiota in mice. Front Pharmacol
10:1652.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7000629</ArticleId>
            <ArticleId IdType="pubmed">32063856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu H, Liu B. (2019). Triptolide-targeted delivery methods. Eur J Med Chem
164:342–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30605832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamada A, Arakaki R, Saito M, et al.  (2016). Role of regulatory T cell in the pathogenesis of inflammatory bowel disease. World J Gastroenterol
22:2195–205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4734996</ArticleId>
            <ArticleId IdType="pubmed">26900284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y, Yan H, Jing M, et al.  (2016). Andrographolide derivative AL-1 ameliorates TNBS-induced colitis in mice: involvement of NF-кB and PPAR-γ signaling pathways. Sci Rep
6:29716.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4951727</ArticleId>
            <ArticleId IdType="pubmed">27435110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan K, Li X, Lu Q, et al.  (2019). Application and mechanisms of triptolide in the treatment of inflammatory diseases—a review. Front Pharmacol
10:1469.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6908995</ArticleId>
            <ArticleId IdType="pubmed">31866868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang G, Chen J, Liu Y, et al.  (2013). Triptolide-conditioned dendritic cells induce allospecific T-cell regulation and prolong renal graft survival. J Invest Surg
26:191–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23514053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang H, Gong C, Qu L, et al.  (2016). Therapeutic effects of triptolide via the inhibition of IL-1beta expression in a mouse model of ulcerative colitis. Exp Ther Med
12:1279–86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4997980</ArticleId>
            <ArticleId IdType="pubmed">27588050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Ma X. (2010). Triptolide inhibits IL-12/IL-23 expression in APCs via CCAAT/enhancer-binding protein alpha. J Immunol
184:3866–77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2965075</ArticleId>
            <ArticleId IdType="pubmed">20194724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao J, Xie C, Mu X, et al.  (2018). Metabolic alterations in triptolide-induced acute hepatotoxicity. Biomed Chromatogr
32:e4299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6150827</ArticleId>
            <ArticleId IdType="pubmed">29799631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao Q, Yang WR, Wang XH, et al.  (2019b). Clostridium butyricum alleviates intestinal low-grade inflammation in TNBS-induced irritable bowel syndrome in mice by regulating functional status of lamina propria dendritic cells. World J Gastroenterol
25:5469–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6767978</ArticleId>
            <ArticleId IdType="pubmed">31576093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao X, Tang X, Yan Q, et al.  (2019a). Triptolide ameliorates lupus via the induction of miR-125a-5p mediating Treg upregulation. Int Immunopharmacol
71:14–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30861393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu KJ, Shen QY, Cheng H, et al.  (2005). Triptolide affects the differentiation, maturation and function of human dendritic cells. Int Immunopharmacol
5:1415–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15953568</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
